Cargando…

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals

Pitavastatin is a potent HMG-CoA reductase inhibitor and efficient hepatocyte low-density lipoprotein cholesterol (LDL-C) receptor inducer, producing robust reduction of the serum LDL-C levels, even at a low dose. Pitavastatin and its lactone form are minimally metabolized by CYP enzymes, and are th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Saito, Yasushi
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788597/ https://www.ncbi.nlm.nih.gov/pubmed/19997573

Ejemplares similares

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals
por: Morimoto, Satoshi, et al.
Publicado: (2010)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
por: Basile, Jan
Publicado: (2010)

Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia
por: Yamasaki, Tomohiro, et al.
Publicado: (2014)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
por: Laffer, Cheryl L, et al.
Publicado: (2011)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Clinical considerations of lipid target and goal in dyslipidemia control
por: Wu, Na-Qiong, et al.
Publicado: (2016)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
por: Wongprikorn, Asita, et al.
Publicado: (2016)

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Hussein, Ayman A, et al.
Publicado: (2010)

Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea
por: Kim, Siin, et al.
Publicado: (2020)

Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?
por: Lee, Jeongmin, et al.
Publicado: (2022)

A critical appraisal of the maternal and child health scenario in a metropolitan city in India with reference to achievements of millennium development goals
por: Mohapatra, Anuradha, et al.
Publicado: (2019)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL–C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study
por: Ding, Rongjing, et al.
Publicado: (2017)

Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin-Treated Subjects From 3 Data Sources: A Retrospective Analysis
por: Jones, Peter H., et al.
Publicado: (2012)

Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
por: Kawai, Yasuyuki, et al.
Publicado: (2011)

Self-Serving Bias in Performance Goal Achievement Appraisals: Evidence From Long-Distance Runners
por: Hyun, Moonsup, et al.
Publicado: (2022)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017)

Critical appraisal of the role of pegloticase in the management of gout
por: Ea, Hang-Korng, et al.
Publicado: (2012)

Additional Treatment with Fenofibrate for Patients Treated with Pitavastatin Under Ordinary Medical Practice for Hypertriglyceridemia in Japan (APPROACH-J Study)
por: Wakida, Yasushi, et al.
Publicado: (2011)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin, Kevin W, et al.
Publicado: (2015)

Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020
por: Rhee, Eun-Jung, et al.
Publicado: (2021)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
por: Ibuki, Chikao, et al.
Publicado: (2012)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2011)

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
por: Pan, Jen-Jung, et al.
Publicado: (2010)

Critical appraisal of the role of serum albumin in cardiovascular disease
por: Chien, Shih-Chieh, et al.
Publicado: (2017)

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
por: Casanova, M, et al.
Publicado: (2011)

Pitavastatin Compared with Differential Intervention Trial by Standard Therapy on Cardiovascular Events in Patients with Dyslipidemia on Chronic Hemodialysis (DIALYSIS): A Randomized Controlled Trial
por: Hamada, Chieko, et al.
Publicado: (2023)

The role of health in achieving the sustainable development goals
por: Acharya, Shambhu, et al.
Publicado: (2018)

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)
por: Al-Kali, Aref, et al.
Publicado: (2010)

A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients
por: Viola, Rebecca A, et al.
Publicado: (2002)

Achieve your goals
por: Smith, Andy
Publicado: (2006)

A Critical Appraisal on the Role of Varicocele in Male Infertility
por: Miyaoka, Ricardo, et al.
Publicado: (2012)

Objective critical appraisal of mammography images in clinical audit: can we achieve this?
por: O'Leary, D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1gu8fb0pu7nj8v4cq774m9fhjq